Anebulo Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top 16 shareholders own 92.54% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
46.3%	Joseph Lawler	12,000,000	€16.8m	0%	no data
20.7%	22NW, LP	5,366,290	€7.5m	0%	5.37%
18%	Aron English	4,654,528	€6.5m	0%	no data
2.47%	LVW Advisors, LLC	641,039	€898.8k	-0.16%	0.12%
1.97%	Nantahala Capital Management, LLC	511,073	€716.5k	0%	0.06%
1.54%	Morgan Stanley, Investment Banking and Brokerage Investments	399,219	€559.7k	0%	no data
0.61%	Ikarian Capital, LLC	157,862	€221.3k	0%	0.07%
0.59%	The Vanguard Group, Inc.	154,036	€216.0k	0.11%	no data
0.34%	Geode Capital Management, LLC	87,790	€123.1k	71.1%	no data
0.073%	Boothbay Fund Management, LLC	18,978	€26.6k	0%	no data
0.015%	BlackRock, Inc.	3,905	€5.5k	3.83%	no data
0.01%	Tower Research Capital Europe Limited	2,694	€3.8k	-18.4%	no data
0.0029%	UBS Asset Management AG	763	€1.1k	0%	no data
0.0014%	Lord, Abbett & Co. LLC	366	€512.7	0%	no data
0.00029%	Bank of America Corporation, Asset Management Arm	76	€105.4	16.9%	no data
0.00003%	JPMorgan Chase & Co, Brokerage and Securities Investments	9	€10.9	-10%	no data